Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

6.595  -0.16 (-2.3%)

Fundamental Rating

3

BLMN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of BLMN while its profitability can be described as average. BLMN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BLMN had positive earnings in the past year.
BLMN had a positive operating cash flow in the past year.
In multiple years BLMN reported negative net income over the last 5 years.
In the past 5 years BLMN always reported a positive cash flow from operatings.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of BLMN (-0.06%) is worse than 64.12% of its industry peers.
BLMN has a Return On Equity of -0.52%. This is comparable to the rest of the industry: BLMN outperforms 51.91% of its industry peers.
BLMN has a Return On Invested Capital of 5.46%. This is comparable to the rest of the industry: BLMN outperforms 50.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLMN is significantly below the industry average of 15.80%.
The 3 year average ROIC (9.55%) for BLMN is well above the current ROIC(5.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROIC 5.46%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN's Operating Margin of 4.59% is on the low side compared to the rest of the industry. BLMN is outperformed by 64.12% of its industry peers.
BLMN's Operating Margin has improved in the last couple of years.
The Gross Margin of BLMN (71.00%) is better than 85.50% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 4.59%
PM (TTM) N/A
GM 71%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
Compared to 1 year ago, BLMN has a worse debt to assets ratio.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, BLMN is doing worse than 70.99% of the companies in the same industry.
The Debt to FCF ratio of BLMN is 35.06, which is on the high side as it means it would take BLMN, 35.06 years of fcf income to pay off all of its debts.
BLMN's Debt to FCF ratio of 35.06 is in line compared to the rest of the industry. BLMN outperforms 41.98% of its industry peers.
BLMN has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BLMN (2.41) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Altman-Z 0.9
ROIC/WACC0.61
WACC9.01%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.41, BLMN is doing worse than 81.68% of the companies in the same industry.
BLMN has a Quick Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a worse Quick ratio (0.33) than 79.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.33
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -37.08% in the last year.
BLMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.30% yearly.
The Revenue has decreased by -5.22% in the past year.
Measured over the past years, BLMN shows a decrease in Revenue. The Revenue has been decreasing by -0.93% on average per year.
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)-5.22%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%

3.2 Future

The Earnings Per Share is expected to decrease by -7.57% on average over the next years.
The Revenue is expected to decrease by -3.20% on average over the next years.
EPS Next Y-31.45%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
EPS Next 5YN/A
Revenue Next Year-11.73%
Revenue Next 2Y-5.37%
Revenue Next 3Y-3.2%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.37 indicates a rather cheap valuation of BLMN.
Compared to the rest of the industry, the Price/Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 98.47% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BLMN to the average of the S&P500 Index (26.54), we can say BLMN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.10, the valuation of BLMN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BLMN is valued cheaper than 96.18% of the companies in the same industry.
BLMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE 4.37
Fwd PE 5.1
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaper than 96.18% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLMN is valued a bit cheaper than 72.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.43
EV/EBITDA 4.16
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A cheap valuation may be justified as BLMN's earnings are expected to decrease with -7.57% in the coming years.
PEG (NY)N/A
PEG (5Y)1.32
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.67%, BLMN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.38, BLMN pays a better dividend. On top of this BLMN pays more dividend than 96.95% of the companies listed in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 9.67%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3723.47%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (8/8/2025, 12:08:58 PM)

6.595

-0.16 (-2.3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners103.97%
Inst Owner Change-0.67%
Ins Owners1.65%
Ins Owner Change7.09%
Market Cap560.97M
Analysts54.44
Price Target9.39 (42.38%)
Short Float %9.06%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 9.67%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-3723.47%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-20 2025-05-20 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.32%
Min EPS beat(2)2.96%
Max EPS beat(2)3.69%
EPS beat(4)3
Avg EPS beat(4)-1.61%
Min EPS beat(4)-13.76%
Max EPS beat(4)3.69%
EPS beat(8)6
Avg EPS beat(8)1.23%
EPS beat(12)10
Avg EPS beat(12)2.7%
EPS beat(16)13
Avg EPS beat(16)4.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-0.32%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)3
Avg Revenue beat(16)-1.56%
PT rev (1m)1.03%
PT rev (3m)-12.92%
EPS NQ rev (1m)5.77%
EPS NQ rev (3m)-22.14%
EPS NY rev (1m)0.9%
EPS NY rev (3m)-5.74%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 4.37
Fwd PE 5.1
P/S 0.15
P/FCF 21.43
P/OCF 2.46
P/B 1.47
P/tB N/A
EV/EBITDA 4.16
EPS(TTM)1.51
EY22.9%
EPS(NY)1.29
Fwd EY19.6%
FCF(TTM)0.31
FCFY4.67%
OCF(TTM)2.68
OCFY40.61%
SpS44.73
BVpS4.47
TBVpS-3.07
PEG (NY)N/A
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.58%
ROICexgc 7.54%
OM 4.59%
PM (TTM) N/A
GM 71%
FCFM 0.69%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Debt/EBITDA 2.66
Cap/Depr 118.44%
Cap/Sales 5.3%
Interest Coverage 2.88
Cash Conversion 66.07%
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.33
Altman-Z 0.9
F-Score6
WACC9.01%
ROIC/WACC0.61
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
EPS Next Y-31.45%
EPS Next 2Y-15.26%
EPS Next 3Y-7.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.22%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%
Revenue Next Year-11.73%
Revenue Next 2Y-5.37%
Revenue Next 3Y-3.2%
Revenue Next 5YN/A
EBIT growth 1Y-46.89%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.57%
EBIT Next 3Y12.2%
EBIT Next 5YN/A
FCF growth 1Y-86.19%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-47.45%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%